h2h pharmacy limited
h2h pharmacy limited Company Information
Company Number
05004312
Next Accounts
51 days late
Directors
Shareholders
lime groves (sittingbourne) limited
Group Structure
View All
Industry
Dispensing chemist in specialised stores
Registered Address
sovereign house, 1-2 bingham road, sittingbourne, kent, ME10 3SU
Website
-h2h pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of H2H PHARMACY LIMITED at £20m based on a Turnover of £50m and 0.4x industry multiple (adjusted for size and gross margin).
h2h pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of H2H PHARMACY LIMITED at £3.5m based on an EBITDA of £761.3k and a 4.58x industry multiple (adjusted for size and gross margin).
h2h pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of H2H PHARMACY LIMITED at £2.2m based on Net Assets of £1.1m and 2.09x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
H2h Pharmacy Limited Overview
H2h Pharmacy Limited is a live company located in sittingbourne, ME10 3SU with a Companies House number of 05004312. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in December 2003, it's largest shareholder is lime groves (sittingbourne) limited with a 100% stake. H2h Pharmacy Limited is a mature, large sized company, Pomanda has estimated its turnover at £50m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
H2h Pharmacy Limited Health Check
Pomanda's financial health check has awarded H2H Pharmacy Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 5 areas for improvement. Company Health Check FAQs
2 Strong
4 Regular
5 Weak
Size
annual sales of £50m, make it larger than the average company (£11.9m)
£50m - H2h Pharmacy Limited
£11.9m - Industry AVG
Growth
3 year (CAGR) sales growth of 6%, show it is growing at a similar rate (6%)
6% - H2h Pharmacy Limited
6% - Industry AVG
Production
with a gross margin of 3.9%, this company has a higher cost of product (32.6%)
3.9% - H2h Pharmacy Limited
32.6% - Industry AVG
Profitability
an operating margin of 1.5% make it less profitable than the average company (3.5%)
1.5% - H2h Pharmacy Limited
3.5% - Industry AVG
Employees
with 16 employees, this is below the industry average (75)
16 - H2h Pharmacy Limited
75 - Industry AVG
Pay Structure
on an average salary of £28.9k, the company has an equivalent pay structure (£24.5k)
£28.9k - H2h Pharmacy Limited
£24.5k - Industry AVG
Efficiency
resulting in sales per employee of £3.1m, this is more efficient (£143.8k)
£3.1m - H2h Pharmacy Limited
£143.8k - Industry AVG
Debtor Days
it gets paid by customers after 36 days, this is near the average (30 days)
36 days - H2h Pharmacy Limited
30 days - Industry AVG
Creditor Days
its suppliers are paid after 35 days, this is quicker than average (66 days)
35 days - H2h Pharmacy Limited
66 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - H2h Pharmacy Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 18 weeks, this is average cash available to meet short term requirements (15 weeks)
18 weeks - H2h Pharmacy Limited
15 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 86.3%, this is a higher level of debt than the average (59.1%)
86.3% - H2h Pharmacy Limited
59.1% - Industry AVG
H2H PHARMACY LIMITED financials
H2H Pharmacy Limited's latest turnover from March 2023 is £50 million and the company has net assets of £1.1 million. According to their latest financial statements, H2H Pharmacy Limited has 16 employees and maintains cash reserves of £2.4 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 49,979,272 | 47,083,908 | 43,537,571 | 42,265,451 | 39,496,584 | 34,019,541 | 31,819,131 | 27,318,574 | 24,664,713 | 22,165,834 | 21,696,963 | 19,759,094 | ||
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Cost Of Sales | 48,044,485 | 45,466,145 | 42,060,384 | 41,247,853 | 37,621,691 | 31,991,628 | 19,954,214 | 18,224,967 | ||||||
| Gross Profit | 1,934,787 | 1,617,763 | 1,477,187 | 1,017,598 | 1,874,893 | 2,027,913 | 1,742,749 | 1,534,127 | ||||||
| Admin Expenses | 1,203,029 | 903,187 | 690,822 | 640,752 | 898,926 | 774,196 | 645,857 | 438,806 | ||||||
| Operating Profit | 731,758 | 714,576 | 786,365 | 376,846 | 975,967 | 1,253,717 | 569,787 | 888,188 | 1,097,000 | 688,012 | 1,096,892 | 1,095,321 | ||
| Interest Payable | 1,875 | 1,644 | 523 | 0 | 1,649 | 0 | 0 | 0 | 0 | 3,777 | 0 | 0 | ||
| Interest Receivable | 1,196 | 791 | 0 | 0 | 131 | 605 | 249 | 711 | 251 | 3,261 | 1,366 | 224 | ||
| Pre-Tax Profit | 731,079 | 713,723 | 785,842 | 376,846 | 974,449 | 1,254,322 | 570,036 | 888,899 | 1,097,251 | 687,496 | 1,098,258 | 1,095,545 | ||
| Tax | -139,541 | -138,236 | -149,310 | -71,608 | -185,227 | -243,872 | -122,857 | -204,616 | -263,788 | -177,964 | -307,609 | -306,960 | ||
| Profit After Tax | 591,538 | 575,487 | 636,532 | 305,238 | 789,222 | 1,010,450 | 447,179 | 684,283 | 833,463 | 509,532 | 790,649 | 788,585 | ||
| Dividends Paid | 2,008,000 | 612,500 | 12,400 | 0 | 0 | 500,000 | 4,544,231 | 0 | 0 | 0 | 0 | 0 | ||
| Retained Profit | -1,416,462 | -37,013 | 624,132 | 305,238 | 789,222 | 510,450 | -4,097,052 | 684,283 | 833,463 | 509,532 | 790,649 | 788,585 | ||
| Employee Costs | 461,723 | 582,908 | 607,467 | 557,529 | 746,062 | 704,536 | 657,805 | 608,808 | 575,993 | 487,296 | 608,366 | 412,660 | ||
| Number Of Employees | 16 | 16 | 17 | 17 | 18 | 19 | 19 | 14 | 14 | 11 | 11 | 11 | 12 | 12 |
| EBITDA* | 761,266 | 738,613 | 793,350 | 378,853 | 977,166 | 1,255,006 | 571,241 | 889,012 | 1,097,953 | 689,281 | 1,098,499 | 1,096,156 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 109,704 | 42,471 | 66,508 | 4,013 | 5,000 | 1,003 | 1,911 | 2,624 | 2,964 | 1,689 | 1,955 | 2,543 | 3,181 | 1,709 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 109,704 | 42,471 | 66,508 | 4,013 | 5,000 | 1,003 | 1,911 | 2,624 | 2,964 | 1,689 | 1,955 | 2,543 | 3,181 | 1,709 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 4,963,959 | 4,441,076 | 7,757,348 | 7,041,256 | 6,449,686 | 5,764,087 | 5,555,815 | 5,842,564 | 5,437,240 | 4,377,837 | 4,376,173 | 4,056,418 | 3,768,337 | 2,974,228 |
| Group Debtors | 0 | 767,469 | 1,579,969 | 1,210,000 | 0 | 0 | 1,280 | 915 | 565 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 375,568 | 243,359 | 351,632 | 334,585 | 424,610 | 315,689 | 296,202 | 216,231 | 6,864 | 3,454,503 | 3,148,899 | 3,333,978 | 2,324,778 | 2,373,186 |
| Cash | 2,395,949 | 1,375,808 | 44,415 | 484,974 | 846,845 | 367,124 | 1,136,833 | 1,381,755 | 965,077 | 1,688,764 | 1,100,768 | 461,017 | 1,170,859 | 637,757 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 7,735,476 | 6,827,712 | 9,733,364 | 9,070,815 | 7,721,141 | 6,446,900 | 6,990,130 | 7,441,465 | 6,409,746 | 9,521,104 | 8,625,840 | 7,851,413 | 7,263,974 | 5,985,171 |
| total assets | 7,845,180 | 6,870,183 | 9,799,872 | 9,074,828 | 7,726,141 | 6,447,903 | 6,992,041 | 7,444,089 | 6,412,710 | 9,522,793 | 8,627,795 | 7,853,956 | 7,267,155 | 5,986,880 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 4,727,632 | 4,126,378 | 5,108,642 | 7,013,281 | 5,831,635 | 5,210,855 | 5,224,723 | 5,523,252 | 5,185,546 | 4,136,178 | 3,740,940 | 3,881,424 | 3,648,392 | 3,190,663 |
| Group/Directors Accounts | 1,828,072 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 2,610 | 3,602 | 2,202 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 21,644 | 20,926 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 203,520 | 205,659 | 2,093,127 | 158,723 | 296,732 | 429,256 | 261,399 | 217,653 | 34,362 | 97,018 | 281,657 | 198,084 | 352,732 | 322,623 |
| total current liabilities | 6,759,224 | 4,353,681 | 7,222,695 | 7,172,004 | 6,128,367 | 5,640,111 | 5,486,122 | 5,740,905 | 5,219,908 | 4,233,197 | 4,022,597 | 4,082,118 | 4,004,726 | 3,515,488 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 16,703 | 38,347 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 13,237 | 10,618 | 12,636 | 762 | 950 | 190 | 363 | 525 | 593 | 355 | 240 | 343 | 466 | 78 |
| total long term liabilities | 13,237 | 27,321 | 50,983 | 762 | 950 | 190 | 363 | 525 | 593 | 355 | 240 | 343 | 466 | 78 |
| total liabilities | 6,772,461 | 4,381,002 | 7,273,678 | 7,172,766 | 6,129,317 | 5,640,301 | 5,486,485 | 5,741,430 | 5,220,501 | 4,233,552 | 4,022,837 | 4,082,461 | 4,005,192 | 3,515,566 |
| net assets | 1,072,719 | 2,489,181 | 2,526,194 | 1,902,062 | 1,596,824 | 807,602 | 1,505,556 | 1,702,659 | 1,192,209 | 5,289,241 | 4,604,958 | 3,771,495 | 3,261,963 | 2,471,314 |
| total shareholders funds | 1,072,719 | 2,489,181 | 2,526,194 | 1,902,062 | 1,596,824 | 807,602 | 1,505,556 | 1,702,659 | 1,192,209 | 5,289,241 | 4,604,958 | 3,771,495 | 3,261,963 | 2,471,314 |
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | 731,758 | 714,576 | 786,365 | 376,846 | 975,967 | 1,253,717 | 569,787 | 888,188 | 1,097,000 | 688,012 | 1,096,892 | 1,095,321 | ||
| Depreciation | 29,508 | 24,037 | 6,985 | 2,007 | 1,199 | 675 | 938 | 1,289 | 1,454 | 824 | 953 | 1,269 | 1,607 | 835 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | -139,541 | -138,236 | -149,310 | -71,608 | -185,227 | -243,872 | -122,857 | -204,616 | -263,788 | -177,964 | -307,609 | -306,960 | ||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -112,377 | -4,237,045 | 1,103,108 | 1,711,545 | 794,520 | 226,479 | -206,413 | 615,041 | -2,387,671 | 307,268 | 134,676 | 1,297,281 | 745,701 | 5,347,414 |
| Creditors | 601,254 | -982,264 | -1,904,639 | 1,181,646 | 620,780 | -13,868 | -298,529 | 337,706 | 1,049,368 | 395,238 | -140,484 | 233,032 | 457,729 | 3,190,663 |
| Accruals and Deferred Income | -2,139 | -1,887,468 | 1,934,404 | -138,009 | -132,524 | 167,857 | 43,746 | 183,291 | -62,656 | -184,639 | 83,573 | -154,648 | 30,109 | 322,623 |
| Deferred Taxes & Provisions | 2,619 | -2,018 | 11,874 | -188 | 760 | -173 | -162 | -68 | 238 | 115 | -103 | -123 | 388 | 78 |
| Cash flow from operations | 1,335,836 | 1,965,672 | -417,429 | -360,851 | 486,435 | 917,022 | 3,823,005 | 587,842 | 642,475 | -707,703 | 533,415 | -1,044,854 | ||
| Investing Activities | ||||||||||||||
| capital expenditure | -3,419 | -949 | -2,729 | -558 | -365 | -631 | -3,079 | 0 | ||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | -3,419 | -949 | -2,729 | -558 | -365 | -631 | -3,079 | 0 | ||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 1,828,072 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 1 | -2,610 | -992 | 1,400 | 2,202 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | -38,347 | -20,926 | 59,273 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | -679 | -853 | -523 | 0 | -1,518 | 605 | 249 | 711 | 251 | -516 | 1,366 | 224 | ||
| cash flow from financing | 1,789,046 | -21,779 | 58,750 | 0 | -1,518 | 605 | 268 | 712 | -2,359 | -1,508 | 2,766 | 1,685,155 | ||
| cash and cash equivalents | ||||||||||||||
| cash | 1,020,141 | 1,331,393 | -440,559 | -361,871 | 479,721 | -769,709 | -244,922 | 416,678 | -723,687 | 587,996 | 639,751 | -709,842 | 533,102 | 637,757 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 1,020,141 | 1,331,393 | -440,559 | -361,871 | 479,721 | -769,709 | -244,922 | 416,678 | -723,687 | 587,996 | 639,751 | -709,842 | 533,102 | 637,757 |
h2h pharmacy limited Credit Report and Business Information
H2h Pharmacy Limited Competitor Analysis
Perform a competitor analysis for h2h pharmacy limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other large companies, companies in ME10 area or any other competitors across 12 key performance metrics.
h2h pharmacy limited Ownership
H2H PHARMACY LIMITED group structure
H2H Pharmacy Limited has no subsidiary companies.
Ultimate parent company
H2H PHARMACY LIMITED
05004312
h2h pharmacy limited directors
H2H Pharmacy Limited currently has 1 director, Mr Balbinder Dhariwal serving since Mar 2019.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Balbinder Dhariwal | England | 60 years | Mar 2019 | - | Director |
P&L
March 2023turnover
50m
+6%
operating profit
731.8k
+2%
gross margin
3.9%
+12.67%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
1.1m
-0.57%
total assets
7.8m
+0.14%
cash
2.4m
+0.74%
net assets
Total assets minus all liabilities
h2h pharmacy limited company details
company number
05004312
Type
Private limited with Share Capital
industry
47730 - Dispensing chemist in specialised stores
incorporation date
December 2003
age
22
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
March 2023
previous names
N/A
accountant
-
auditor
SMAILES GOLDIE
address
sovereign house, 1-2 bingham road, sittingbourne, kent, ME10 3SU
Bank
LLOYDS TSB BANK PLC
Legal Advisor
-
h2h pharmacy limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to h2h pharmacy limited.
h2h pharmacy limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for H2H PHARMACY LIMITED. This can take several minutes, an email will notify you when this has completed.
h2h pharmacy limited Companies House Filings - See Documents
| date | description | view/download |
|---|
